Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market: By Product Type (Drug Eluting Balloons, Normal Balloons, Scoring Balloons, Cutting Balloons), By Application (Peripheral Artery Disease, Coronary Artery Disease), By End Users (Hospitals, Clinics, Ambulatory Surgical Centers), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023
Market Dynamics: Percutaneous Transluminal Angioplasty (PTA) Balloons Market
Percutaneous transluminal angioplasty (PTA) is a process carried to treat the peripheral artery disease (PAD) by open up the arteries that are narrowed by plaque. Increase in the prevalence of peripheral or coronary artery diseases, development in imaging technologies, recent launch of several percutaneous transluminal angioplasty balloons, and rise in R&D for the manufacturing of advanced technology balloons such as drug-eluting balloons are anticipated to fuel the percutanleous transluminal angioplasty balloons market over the forecast period. However, stringent guidelines for product approval, high cost of PTA balloons, and lack of awareness about advanced PTA balloons in underdeveloped countries may restrain the growth of percutaneous transluminal angioplasty balloons market.
A sample of this report is available upon request @
Market Scope: Percutaneous Transluminal Angioplasty (PTA) Balloons Market
Percutaneous transluminal angioplasty balloons market is segmented on the basis of product type, application, end user, and region.
Based on the product type, the market is segmented into the following:
- Drug-Eluting Balloons
- Normal Balloons
- Scoring Balloons
- Cutting Balloons
Based on the application, the market is segmented into the following:
- Peripheral Artery Disease
- Coronary Artery Disease
Base on the end user, the market is segmented into the following:
- Hospitals
- Cardiology Clinics
- Ambulatory Surgical Centers
Based on the region, the market is segmented into the following:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Regional Analysis: Percutaneous Transluminal Angioplasty (PTA) Balloons Market
Geographically, global percutaneous transluminal angioplasty (PTA) balloons market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa regions. North America percutaneous transluminal angioplasty balloons market growth driven by rise in prevalence of peripheral and coronary artery diseases, rise in R&D for the innovation of advanced products, and sophisticated healthcare infrastructure in the region. Europe percutaneous transluminal angioplasty balloons market accounted for significant share due to rise in R&D activities by the Europe companies, high adoption of advanced PTA balloons by healthcare professionals, and increase in healthcare expenditure. Asia Pacific percutaneous transluminal angioplasty balloons market is poised to grow at significant rate due to rise in prevalence of coronary and peripheral artery diseases, increase in geriatric population and prevalence of diabetes, rise in medical tourism in Asia Pacific countries are anticipated to propel the market. Latin America percutaneous transluminal angioplasty balloons market has a lucrative growth, which is attributed to expansion of the businesses by the market players, rise in prevalence of artery diseases, and conomic growth. Middle East and Africa percutaneous transluminal angioplasty balloons market expected to present better growth opportunity for market players owing to rise in awareness about PTA balloons in South Africa, and rise in prevalence of artery diseases in Middle East region.
To view TOC of this report is available upon request @
Competition Assessment: Percutaneous Transluminal Angioplasty (PTA) Balloons Market
Key players profiles in the global percutaneous transluminal angioplasty (PTA) balloons market include:
- Bard, Inc. (U.S.)
- Cook Medical, Inc. (U.S.)
- Abbott, Inc. (U.S.)
- Cardinal Health, Inc. (U.S.)
- Boston Scientific Corporation (U.S.)
- Spectranetics Corporation (Philips Holding USA Inc.) (U.S.)
- Medtronic Plc (Ireland)
- SurModics Inc. (U.S.)
- ENDOCOR GmbH (Germany)
Need more information about this report @
Notable Market Developments: Percutaneous Transluminal Angioplasty (PTA) Balloons Market
In September 2017, SurModics Inc. received FDA and CE mark approval for its .014” low-profile PTA balloon dilation catheter used for peripheral angioplasty procedures.
Get access to full summary @
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553